Md. Code Ann., Agric. § 3-1001
Definitions
Effective Oct 1, 2019Added by Acts 2017, c. 787, § 1, eff. Oct. 1, 2017; Acts 2017, c. 788, § 1, eff. Oct. 1, 2017. Amended by Acts 2019, c. 678, § 1, eff. Oct. 1, 2019; Acts 2019, c. 679, § 1, eff. Oct. 1, 2019.State of Maryland
- (a) In this subtitle the following words have the meanings indicated.
(b) “Administered in a regular pattern” means used:
- (1) For multiple courses of therapy in the same animal or group of animals; or
(2) As standard operating procedure, including:
- (i) In correspondence with a particular life stage of an animal, such as in ovo, at birth or hatch, or at weaning;
(ii) As an ongoing management strategy or tool, such as in correspondence with a particular:
- 1. Age or weight of an animal;
- 2. Time of the week, month, or year; or
- 3. Season; or
- (iii) When moving animals from one location to another.
(c) “Control the spread of disease or infection” means to contain the transmission of a documented disease or infection present in:
- (1) A group of animals in contact with each other; or
- (2) A barn or equivalent animal housing unit.
- (d) “Documented” means acknowledged and recorded.
(e)
- (1) “Elevated risk” means a risk that is significantly higher than that present under normal or standard operating conditions.
- (2) “Elevated risk” does not include a risk typically or frequently present under normal or standard operating conditions.
(f) “Medically important antimicrobial drug” means any drug from a class of drug or derivative of a class of drug that is:
(1)
- (i) Made from a mold or bacterium that kills or slows the growth of other microbes, specifically bacteria; and
- (ii) Used in human beings or intended for use in human beings to treat or prevent disease or infection; or
(2) Listed in:
- (i) Appendix A of the federal Food and Drug Administration's Guidance for Industry #152, including critically important, highly important, or important antimicrobial drugs; or
- (ii) A subsequent guidance document created by the federal Food and Drug Administration that ranks the medical importance of antimicrobial drugs.
(g) “Medically important antimicrobial drug prescription” means an order issued by a veterinarian licensed in the State in the course of the veterinarian's professional practice:
(1) For a medically important antimicrobial drug that is:
- (i) In a water-soluble powder form; and
- (ii) To be added to the drinking water of cattle, swine, or poultry; and
- (2) That provides the same or substantially similar information as the information that is required for a veterinary feed directive under Title 21, § 558.6(b)(3) and (4) of the Code of Federal Regulations.
(h) “Owner” means a person that:
- (1) Has an ownership interest in cattle, swine, or poultry, including a right or an option to purchase the cattle, swine, or poultry; or
- (2) Is otherwise engaged in the business of obtaining live cattle, swine, or poultry under a growing agreement for the purpose of either slaughtering the cattle, swine, or poultry or selling the cattle, swine, or poultry for slaughter.
- (i) “Prophylaxis” means the prevention of disease or infection in the absence of documented clinical signs of disease or infection.
- (j) “Treat a disease or infection” means to resolve clinical signs of infection or disease in an infected animal.
(k) “Veterinary feed directive” means a written statement issued by a veterinarian licensed in the State in the course of the veterinarian's professional practice that:
- (1) Orders the use of an animal drug in or on animal feed;
- (2) Authorizes an owner or a caretaker of an animal to obtain and use animal feed bearing or containing an animal drug to treat the animal; and
- (3) Meets the conditions and requirements specified under Title 21, § 558.6 of the Code of Federal Regulations.
Added by Acts 2017, c. 787, § 1, eff. Oct. 1, 2017; Acts 2017, c. 788, § 1, eff. Oct. 1, 2017. Amended by Acts 2019, c. 678, § 1, eff. Oct. 1, 2019; Acts 2019, c. 679, § 1, eff. Oct. 1, 2019.